Lv6
2620 积分 2025-08-27 加入
FDA’s Regulatory Reforms to Unlock Competition and Lower Drug Costs
1个月前
已关闭
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma
1个月前
已完结
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma
1个月前
已完结
Substantial global carbon uptake by cement carbonation
3个月前
已完结
Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors
3个月前
已完结
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study
3个月前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
3个月前
已完结
Phase 1 Study of Luvometinib Use in Pediatric Patients with Neurofibromatosis Type 1-Related Unresectable Plexiform Neurofibromas
3个月前
已关闭
Characteristics of drugs approved in Japan without conducting confirmatory clinical trials
3个月前
已完结
Characteristics of drugs approved in Japan without conducting confirmatory clinical trials
3个月前
已完结
Nitrogen‐Rich MOF‐Material‐Derived Metal Dual‐Atom Platforms for Efficient Electrochemical Nitrate Reduction
3个月前
已采纳
Nitrogen‐Rich MOF‐Material‐Derived Metal Dual‐Atom Platforms for Efficient Electrochemical Nitrate Reduction
3个月前
已撤回
Intelligent distribution network active protection and fault recovery mechanism based on DRL and graph optimization
3个月前
已采纳
太赫兹区域的超表面驱动传感：原理、应用、制造和挑战
3个月前
已采纳
可降解木质素基室温磷光材料的制备与应用研究
3个月前
已采纳
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
4个月前
已采纳
Component analysis using UPLC-Q-Exactive Orbitrap-HRMS and quality control of Kudingcha (Ligustrum robustum (Roxb.) Blume)
5个月前
已采纳
富锂层状氧化物正极材料中阳离子排布的调控及电化学性能研究
5个月前
已采纳
Effective promotion of oxygen reduction activity by rare earth doping in simple perovskite cathodes for intermediate-temperature solid oxide fuel cells
5个月前
已采纳
皖公网安备34019202002308
